Dark

ANTH
ANTHERA PHARMS INC NEW
stock OTC

Inactive

Dec 31, 2021

0.000100USD0.000%(0.000000)17,752

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Headquarters

Hayward, California, USA

Industry

Biotechnology

Last Split

May 1, 20171for8reverse

VIVO DRNA AFMD VKTX XLV

Profile

anthera pharmaceuticals, inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. anthera has two product candidates, sollpura, in phase 3 development for exocrine pancreatic insufficiency due to cystic fibrosis and blisibimod, in phase 2 development for iga nephropathy. nasdaq: anth

document.getElementById("R9qXVc").onerror = function(){this.style.display='none';}; .dark-mode .RlCP0p{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .RlCP0p{ color: #333333; background-color: white; border: 2px solid #333333; }ANTHANTHERA PHARMS INC NEWstock OTC

ANTH
ANTHERA PHARMS INC NEW
stock OTC